RIM
GILD icon

RS Investment Management’s Gilead Sciences GILD Stock Holding History

RS Investment Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		$2.46M Sell
29,512
-121,590
-80% -$10.8M 0.03% 301
2016
Q1 		$13.9M Sell
151,102
-4,129
-3% -$372K 0.14% 216
2015
Q4 		$15.7M Sell
155,231
-1,272
-0.8% -$132K 0.14% 207
2015
Q3 		$15.4M Buy
156,503
+30,663
+24% +$3.41M 0.14% 201
2015
Q2 		$14.7M Sell
125,840
-18,980
-13% -$2.07M 0.13% 219
2015
Q1 		$14.2M Sell
144,820
-45,640
-24% -$4.63M 0.13% 214
2014
Q4 		$17.9M Buy
190,460
+38,581
+25% +$3.99M 0.16% 207
2014
Q3 		$16.2M Sell
151,879
-40,735
-21% -$3.99M 0.15% 195
2014
Q2 		$16M Buy
192,614
+12,400
+7% +$965K 0.13% 198
2014
Q1 		$12.8M Buy
180,214
+17,734
+11% +$1.39M 0.08% 217
2013
Q4 		$12.2M Sell
162,480
-28,000
-15% -$1.95M 0.07% 211
2013
Q3 		$12M Sell
190,480
-3,200
-2% -$191K 0.08% 200
2013
Q2 		$9.92M Buy
+193,680
New +$10.1M 0.07% 203

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

RS Investment Management's GILD Position: Q2 2016 in Review

RS Investment Management reduced its Gilead Sciences (GILD) stake by 80% in Q2 2016, selling an estimated $10.8M and leaving 29,512 shares worth $2.46M. The position accounts for 0.03% of the portfolio, ranked #301.

RS Investment Management first reported a position in GILD in Q2 2013 and has held it in 13 quarters since. The position peaked at $17.9M in Q4 2014. 1,597 funds tracked by Wall St. Rank hold GILD as of Q2 2016.

  • RS Investment Management held 29,512 shares of Gilead Sciences worth $2.46M as of Q2 2016.
  • RS Investment Management sold 121,590 Gilead Sciences shares in Q2 2016, an estimated $10.8M.
  • Gilead Sciences made up 0.03% of RS Investment Management's portfolio in Q2 2016, its #301 holding.
  • RS Investment Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 13 quarters since.
  • RS Investment Management's Gilead Sciences position peaked at $17.9M in Q4 2014.
  • 1,597 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2016.

Based on RS Investment Management's 13F filing for Q2 2016, filed 26 Jul 2016.